PANTHERx® Chairman and CEO, Dr. Gordon J. Vanscoy, has been invited to join world business leaders at the 36th annual J.P. Morgan Healthcare Conference, January 8-11, at the Westin St. Francis in San Francisco.  Focused on companies that are shaping today and tomorrow’s healthcare industry, the conference brings together healthcare executives, representatives from dynamic, fast-growing organizations, technology innovators, and investors.

As THE Rare Disease Specialty Pharmacy®, PANTHERx’s mission is to Reinvent Specialty, Revolutionize Pharmacy, and Redefined Care®, by developing solutions, bold innovations, and novel clinical services for emerging orphan and rare disease therapies. Gordon’s attendance represents the continued focus of PANTHERx® to serve patients and partners in the delicate journey to manage rare and devastating conditions as critical cures and lifesaving pharmaceuticals emerge.

Connect with Dr. Vanscoy by emailing his Executive Administrator, Lisa Nacey at mailto:lnacey@pantherspecialty.com to prepare an introduction or appointment.